Cargando…
Exploring synthetic lethal network for the precision treatment of clear cell renal cell carcinoma
The emerging targeted therapies have revolutionized the treatment of advanced clear cell renal cell carcinoma (ccRCC) over the past 15 years. Nevertheless, lack of personalized treatment limits the development of effective clinical guidelines and improvement of patient prognosis. In this study, larg...
Autores principales: | Liu, Zhicheng, Lin, Dongxu, Zhou, Yi, Zhang, Linmeng, Yang, Chen, Guo, Bin, Xia, Feng, Li, Yan, Chen, Danyang, Wang, Cun, Chen, Zhong, Leng, Chao, Xiao, Zhenyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345903/ https://www.ncbi.nlm.nih.gov/pubmed/35918352 http://dx.doi.org/10.1038/s41598-022-16657-7 |
Ejemplares similares
-
Mapping the landscape of synthetic lethal interactions in liver cancer
por: Yang, Chen, et al.
Publicado: (2021) -
Exploring a ferroptosis and oxidative stress-based prognostic model for clear cell renal cell carcinoma
por: Lin, Dongxu, et al.
Publicado: (2023) -
Synthetic lethality of cyclin-dependent kinase inhibitor Dinaciclib with VHL-deficiency allows for selective targeting of clear cell renal cell carcinoma
por: Nelson, Luke J, et al.
Publicado: (2022) -
Inflammatory response-based prognostication and personalized therapy decisions in clear cell renal cell cancer to aid precision oncology
por: Zhong, Weimin, et al.
Publicado: (2023) -
Patient-derived organoids potentiate precision medicine in advanced clear cell renal cell carcinoma
por: Xue, Yizheng, et al.
Publicado: (2022)